BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

557 related articles for article (PubMed ID: 9186325)

  • 21. Intravesical epirubicin treatment following TUR in superficial bladder tumours.
    Imamoğlu MA; Bakirtaş H; Yiğitbaşi O; Ersoy H; Sertçelik AN
    Arch Esp Urol; 2001 Dec; 54(10):1147-53. PubMed ID: 11852530
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A single instillation of epirubicin after transurethral resection of bladder tumors prevents only small recurrences.
    Berrum-Svennung I; Granfors T; Jahnson S; Boman H; Holmäng S
    J Urol; 2008 Jan; 179(1):101-5; discussion 105-6. PubMed ID: 17997459
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Randomized study of single early instillation of (2"R)-4'-O-tetrahydropyranyl-doxorubicin for a single superficial bladder carcinoma.
    Okamura K; Ono Y; Kinukawa T; Matsuura O; Yamada S; Ando T; Fukatsu T; Ohno Y; Ohshima S;
    Cancer; 2002 May; 94(9):2363-8. PubMed ID: 12015761
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intravesical chemotherapy with epirubicin: a dose response study.
    Masters JR; Popert RJ; Thompson PM; Gibson D; Coptcoat MJ; Parmar MK
    J Urol; 1999 May; 161(5):1490-3. PubMed ID: 10210379
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Short-term intravesical instillation of pirarubicin (THP) in prophylactic treatment after transurethral resection of superficial bladder tumor].
    Kuroda K; Ishii N; Fukasawa K; Shirai M; Tajima M; Matsushima M; Miura K; Takanami M; Matsuhashi M; Kuwabara T; Matsumoto H; Sugita M
    Hinyokika Kiyo; 1998 Aug; 44(8):547-52. PubMed ID: 9783189
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sustained prophylactic effect of intravesical bacille Calmette-Guérin for superficial bladder cancer: a smoothed hazard analysis in a randomized prospective study.
    Hinotsu S; Akaza H; Isaka S; Kanetake H; Kubota Y; Kuroda M; Shinohara N; Shinka T; Tachibana M; Naito S; Hirao Y;
    Urology; 2006 Mar; 67(3):545-9. PubMed ID: 16527576
    [TBL] [Abstract][Full Text] [Related]  

  • 27. TUR and adjuvant intravesical chemotherapy in T1G3 bladder tumors: recurrence, progression and survival in 137 selected patients followed up to 20 years.
    Serretta V; Pavone C; Ingargiola GB; Daricello G; Allegro R; Pavone-Macaluso M
    Eur Urol; 2004 Jun; 45(6):730-5; discussion 735-6. PubMed ID: 15149744
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [A randomized study of prophylactic intravesical instillation of pirarubicin (THP) prior to transurethral resection of superficial bladder cancer].
    Hashimura T; Shirahase T; Inoue T; Yamasaki T; Terada N; Ogura K; Arai Y; Hida S; Ueda T
    Hinyokika Kiyo; 2005 Jul; 51(7):439-42. PubMed ID: 16119805
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of intravesical chemotherapy on recurrence rate of recurrent superficial transitional cell carcinoma of the bladder: results of a meta-analysis.
    Huncharek M; McGarry R; Kupelnick B
    Anticancer Res; 2001; 21(1B):765-9. PubMed ID: 11299841
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Postoperative intravesical instillation of THP for superficial bladder tumor: clinical results of prophylactic effects on the recurrence. Fukushima THP Research Group].
    Aikawa K; Irisawa C; Muraki O; Yamaguchi O; Shiraiwa Y; Noguchi M; Koguchi M; Yokoyama J; Ito K; Kumakawa K
    Gan To Kagaku Ryoho; 1992 Apr; 19(4):509-13. PubMed ID: 1558401
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Twelve-year follow up of a randomized prospective trial comparing bacillus Calmette-Guerin and epirubicin as adjuvant therapy in superficial bladder cancer.
    Cheng CW; Chan SF; Chan LW; Chan CK; Ng CF; Cheung HY; Chan SY; Wong WS; Lai FM; To KF; Li ML
    Int J Urol; 2005 May; 12(5):449-55. PubMed ID: 15948743
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intravesical chemotherapy for maximum prophylaxis of new early phase superficial bladder carcinoma treated by transurethral resection: a combined analysis of trials by the Japanese Urological Cancer Research Group using smoothed hazard function.
    Hinotsu S; Akaza H; Ohashi Y; Kotake T
    Cancer; 1999 Nov; 86(9):1818-26. PubMed ID: 10547556
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adjuvant intravesical mitoxantrone versus recombinant interferon-alpha after transurethral resection of superficial bladder cancer: a randomized prospective study.
    Papatsoris AG; Deliveliotis C; Giannopoulos A; Dimopoulos C
    Urol Int; 2004; 72(4):284-91. PubMed ID: 15153724
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effect of prophylactic treatment with intravesical epirubicin in recurrence of superficial bladder tumor].
    Pérez Mestre M; Cuñat Albert E; Francisco Mingol V; Arrufat Boix JM; Gallego Gómez J
    Arch Esp Urol; 1999 May; 52(4):345-50. PubMed ID: 10380324
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [A clinical study of recurrence and progression of grade 3 superficial bladder tumor].
    Ikegami S; Tsuji A; Suzuki S; Sumitomo M; Kimura F; Asano T; Nakajima F; Hayakawa M
    Hinyokika Kiyo; 1999 May; 45(5):325-9. PubMed ID: 10410314
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunoprophylactic intravesical application of bacillus Calmette-Guerin after transurethral resection of superficial bladder cancer.
    Librenjak D; Situm M; Eterovic D; Dogas Z; Gotovac J
    Croat Med J; 2003 Apr; 44(2):187-92. PubMed ID: 12698510
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Single instillation of epirubicin for the prophylaxis of recurrent primary superficial bladder carcinoma].
    Liu B; Zhang Y; Wang Z; Ding Q; Chen B; Wang J; Jiang H
    Zhonghua Wai Ke Za Zhi; 2002 Feb; 40(2):112-5. PubMed ID: 11955393
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Drug eruption due to intravesical instillations of both epirubicin and mitomycin C.
    Okumura A; Oishi N; Kaji K; Imamura T; Fuse H
    J Dermatol; 2009 Jul; 36(7):419-22. PubMed ID: 19583691
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Single-dose versus multiple instillations of epirubicin as prophylaxis for recurrence after transurethral resection of pTa and pT1 transitional-cell bladder tumours: a prospective, randomized controlled study.
    Ali-el-Dein B; Nabeeh A; el-Baz M; Shamaa S; Ashamallah A
    Br J Urol; 1997 May; 79(5):731-5. PubMed ID: 9158511
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Intravesial instillation of recombination interferon-alpha and pirarubicin in the prophylaxis of local recurrence after resection of the superficial bladder cancer].
    Deng JH; Bai JL; Zhang SS; Ma PC; Wan JH
    Ai Zheng; 2004 Jul; 23(7):839-41. PubMed ID: 15248924
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.